Video

Upperton Pharma Solutions Capabilities Update April 2026: Small Molecule Drug Product

Learn more about UK-CDMO, Upperton Pharma Solutions, and their expertise across oral, nasal, pulmonary and sterile drug product development and manufacturing. Chief Technical Officer, Ian Lafferty, and Business Development Director, Myles Terrey, will provide an overview of Upperton's 60,000 sq. ft facility, CDMO services, and project management approach that makes Upperton perfectly aligned to the needs of small to mid-sized biotech and innovators.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Upperton Pharma Solutions